PrimeC was associated with changes across multiple biomarkers spanning key neurodegenerative disease pathways, providing early biological evidence consistent with potential target engagementFindings support continued development of PrimeC's multi-target approach in Alzheimer's diseaseCAMBRIDGE, Mass., June 25, 2026 /PRNewswire/ –…
News provided by PR Newswire.
